Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company that has developed multiple methods for the manufacturing of various types of gold nanoparticles. The Company is engaged in the research and development of its technology for use in multiplex diagnostic testing platforms and biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of CTAB (cetyltrimethylammonium), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company leverages its core proprietary gold nanorod (GNR) manufacturing technology and laboratory assets to focus on the development of diagnostic tests and biologic reagents, and the advancement of its GNR intellectual property.


CSE:SONA - Post by User

Comment by TheeRookon Aug 06, 2020 10:26pm
202 Views
Post# 31376867

RE:RE:RE:Is this not an overreaction due to impatience?

RE:RE:RE:Is this not an overreaction due to impatience?The minimal results of the MRI Global test data  was on Jul  02 2020


Validation studies were also conducted in house to assess potential clinical performance of the test using 30 nasopharyngeal samples from healthy individuals who were presumed negative for COVID-19. Results from the study generated a specificity of 96 per cent (29/30) and a sensitivity of 96 per cent (28/29). All specimen samples tested generated negative results, except for one, generating the result of 96 per cent. To generate the sensitivity data, the remnants of each negative sample were spiked with gamma-irradiated COVID-19 virus and the tests rerun to determine the positive results, generating the result of 96 per cent.



Mariolanglis wrote: THE ROOK,

YOU ARE SHORT SONA? NO RESULTS HAVE BEEN PUBLISHED YET BY SONA ON RESULTS UNLESS YOU ARE PRIVY TO MATERIAL NON-PUBLIC INFORMATION. IF YOU ARE THEN YOU ARE INFLUENCING A STOCK IN YOUR PERSONAL GAIN AND COULD BE PROSECUTED. 

KEEP POSTING FALSE CLAIMS, I SEE YOU

ML


<< Previous
Bullboard Posts
Next >>